The topical treatment of psoriasis

Clinical and Experimental Dermatology

Volumn 30, Issue 2, 2005, Pages 205-208

  Van De Kerkhof, P C M ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHOSYL; BETAMETHASONE; BETAMETHASONE DIPROPIONATE PLUS CALCIPOTRIOL; CALCINEURIN INHIBITOR; CALCIPOTRIOL; CALCITRIOL; COAL TAR; COLECALCIFEROL; CORTICOSTEROID; CYCLOSPORIN; DITHRANOL; PARICALCITOL; PIMECROLIMUS; RETINOID; TACALCITOL; TACROLIMUS; TAZAROTENE; UNCLASSIFIED DRUG;

ACRODERMATITIS; ATOPIC DERMATITIS; CARCINOGENICITY; CLINICAL TRIAL; DISEASE SEVERITY; DRUG EFFICACY; DRUG FORMULATION; DRUG SAFETY; DRUG TOLERABILITY; HUMAN; PARESTHESIA; PATIENT COMPLIANCE; PHOTOTHERAPY; PRIORITY JOURNAL; PSORIASIS; PUSTULAR PSORIASIS; QUALITY OF LIFE; QUANTITATIVE ANALYSIS; REVIEW; SIDE EFFECT; SKIN IRRITATION; SKIN MANIFESTATION; TREATMENT INDICATION;

ADMINISTRATION, CUTANEOUS; DERMATOLOGIC AGENTS; HUMANS; PATIENT COMPLIANCE; PSORIASIS;

EID: 15044365117     PISSN: 03076938     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2005.01719.x     Document Type: Review

References (21)

1. Feldman SR. A quantitiative definition of severe psoriasis for use in clinical trials. J Dermatol Treatm 2004; 15: 27-9.
2. Zagloul SS, Goodfield MJ. Objective assessment of compliance with psoriasis treatment. Arch Dermatol 2004; 140: 408-14.
3. Balkrishnan R, Carroll CL, Camacho FT, Feldman SR. Electronic monitoring of medication adherence in skin disease: results of a pilot study. J Am Acad Dermatol 2003; 49: 651-4.
4. Carroll ChL, Feldman SR, Camacho FT et al. Adherence to topical therapy decreases during the course of an 8 week psoriasis clinical trial: Commonly used methods of measuring adherence to topical therapy overestimate actual use. J Am Acad Dermatol 2004; 51: 212-6.
5. Swinkels OQJ, Prins M, Veenhuis RT et al. Effectiveness and side effects of UVB-phototherapy, dithranol in patient therapy and a care instruction program of short contact dithranol in moderate to severe psoriasis. Eur J Dermatol 2004; 14: 159-65.
6. Goodfield M, Kownacki S, Berth Jones J. Double-blind randomised, multicentre, parallel group study comparing a 1% coal tar preparation (Exorex) with a 5% coal tar preparation (Alphosyl) in chronic plaque psoriasis. J Dermatol Treatm 2004; 15: 14-22.
7. Pearce DJ, Spencer L, Hu J et al. Psoriasis and phototherapy. J Dermatol Treat 2004; 15: 235-8.
8. Van de Kerkhof PCM, Vissers WHPM. Established treatment of psoriasis. Current drug-targets. Inflammation Allergy 2004; 3: 145-6.
9. -1 ointment on chronic plaque psoriasis localized in facial, hairline, retro auricular and flexural areas. Br J Dermatol 2003; 148: 326-33.
10. Vissers WH, Berends M, Muys L et al. The effect of the combination of calcipotriol and betamethasone dipropionate versus both monotherapies on epidermal proliferation, keratinisation and T-cell subsets in chronic plaque psoriasis. Exp Dermatol 2004; 13: 106-12.
11. Kragballe K, Noerrelund KL, Lui H et al: Efficacy of once daily treatment regimens with calcipotriol/betamethasone dipropionate ointment and calcipotriol ointment in psoriasis vulgaris. Er J Dermatol 2004; 150: 1167-73.
12. R) on the quality of life in patients with psoriasis vulgaris: a randomized controlled trial. Br J Dermatol 2004; 151: 663-8.
13. Roeder A, Schaller M, Schäfer-Korting M, Korting HC. Tazarotene: Therapeutic strategies in the treatment of psoriasis, acne and photoaging. Skin Pharmacol Physiol 2004; 17: 111-8.
14. Veraldi. Short contact therapy with tazarotene in psoriasis vulgaris. Dermatology 2003; 26: 347-8.
15. Weinstein GD, Koo JY, Krueger GG et al. Tazarotene cream in the treatment of psoriasis. Two multicentre double blind, randomized vehicle controlled studies of the safety and efficacy of tazarotene cream applied once daily for 12 weeks. J Am Acad Dermatol 2003; 48: 760-7.
16. Freeman AK, Linmowski GJ, Brady C et al. Tacrolimus ointment for the treatment of psoriasis on the face and intertriginous areas. J Am Acad Dermatol 2003; 48: 564-8.
17. Lebwohl M, Freeman AK, Chapman MS et al. Tacrolimus ointment is effective for facial and intertriginous psoriasis. J Am Acad Dermatol 2004; 51: 723-30.
18. Gribetz C, Ling M, Lebwohl M et al. Pimecrolimus cream 1% in the treatment of intertriginous psoriasis: a double blind, randomized study. J Am Acad Dermatol 2004; 51: 731-8.
19. Nagao K, Ishiko A, Yokoyama T, Tanikawa A, Amagai N. A case of generalised pustular psoriasis treated with topical tacrolimus. Arch Dermatol 2003; 139: 1219.
20. Wilsmann-Theis D, Hagemann T, Dederer H et al. Succesful treatment of acrodermatitis continua suppurativa with topical tacrolimus 0.1% ointment. Br J Dermatol 2004; 1194: 7.
21. 2) is a novel, safe and effective treatment for plaque psoriasis: a pilot study. Br J Dermatol 2004; 151: 190-5.